The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease

Inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease, are disabling conditions characterised by chronic, relapsing inflammation of the gastrointestinal tract. Current treatments are not universally effective or, in the case of therapeutic antibodies, are hampered by immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vries, L.C.S., Wildenberg, M.E., De Jonge, W.J., D’Haens, G.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881740/
https://www.ncbi.nlm.nih.gov/pubmed/28158411
http://dx.doi.org/10.1093/ecco-jcc/jjx003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881740/
https://www.ncbi.nlm.nih.gov/pubmed/28158411
http://dx.doi.org/10.1093/ecco-jcc/jjx003

Ejemplares similares